Impact of External Quality Assurance on the Quality of Xpert MTB/RIF Testing in Viet Nam-Reference-Cited by-同舟云学术

Impact of External Quality Assurance on the Quality of Xpert MTB/RIF Testing in Viet Nam

Published:2019-03 Issue:3 Volume:57 Page:
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Gumma Vidyanidhi¹,DeGruy Kyle²,Bennett Davara³,Nguyen Thi Kim Thanh⁴,Albert Heidi⁵^ORCID,Bond Kyle B.²,Gutreuter Steve²,Alexander Heather²,Ngyuen Thi Phong Lan⁶,Rush Thomas H.⁶,Nguyen Viet Nhung⁷,Nguyen Van Hung⁴

Affiliation:

1. Foundation for Innovative New Diagnostics (FIND), National Lung Hospital, Hanoi, Viet Nam

2. U.S. Centers for Disease Control and Prevention, Atlanta, Georgia, USA

3. Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland

4. National Tuberculosis Reference Laboratory, National Tuberculosis Control Programme, National Lung Hospital, Hanoi, Viet Nam

5. Foundation for Innovative New Diagnostics (FIND), Mowbray, Cape Town, South Africa

6. U.S. Centers for Disease Control and Prevention, Hanoi, Viet Nam

7. National Tuberculosis Control Programme, National Lung Hospital, Hanoi, Viet Nam

Abstract

Following the endorsement of the Xpert MTB/RIF assay (Cepheid, Sunnyvale, CA, USA) by the World Health Organization (WHO) in 2010, Viet Nam’s National Tuberculosis Control Program (NTP) began using GeneXpert instruments in NTP laboratories. In 2013, Viet Nam’s NTP implemented an Xpert MTB/RIF external quality assurance (EQA) program in collaboration with the U.S.

Funder

PEPFAR

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.01669-18

Reference21 articles.

1. World Health Organization. 2016. Global tuberculosis report 2016. World Health Organization Geneva Switzerland. http://apps.who.int/medicinedocs/documents/s23098en/s23098en.pdf.

2. The Fourth National Anti-Tuberculosis Drug Resistance Survey in Viet Nam

3. World Health Organization. 2014. The End TB strategy: global strategy and targets for tuberculosis prevention care and control after 2015. World Health Organization Geneva Switzerland. http://www.who.int/tb/strategy/End_TB_Strategy.pdf?ua=1.

4. Socialist Republic of Viet Nam. 2014. Approving national strategy for tuberculosis prevention and control to 2020 with a view to 2030. Decision 374/QD-TTg. Prime Minister Hanoi Viet Nam. http://www.stoptb.org/assets/documents/countries/partnerships/National%20Strategy%20for%20TB%20control%20in%20VietNam.pdf.

5. World Health Organization. 2013. Automated real-time nucleic acid amplification technology for rapid and simultaneous detection of tuberculosis and rifampicin resistance: Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children. Policy update. World Health Organization Geneva Switzerland. http://apps.who.int/iris/bitstream/10665/112472/1/9789241506335_eng.pdf.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A small-scale external quality assessment for PCR detection of group B streptococcus in China;Clinica Chimica Acta;2024-01

2. Construction and application of a heterogeneous quality control library for the Xpert MTB/RIF assay in tuberculosis diagnosis;Frontiers in Cellular and Infection Microbiology;2023-03-17

3. Advancing proficiency testing for ultra in resource-limited settings using dried tube specimen: A study by SRL-Uganda;PLOS ONE;2023-03-10

4. External quality assessment (EQA) combined with on-site technical evaluation for capacity building in clinical microbiology laboratories in Pakistan;Accreditation and Quality Assurance;2022-03-01

5. Implementation of GeneXpert MTB/Rif proficiency testing program: A Case of the Uganda national tuberculosis reference laboratory/supranational reference laboratory;PLOS ONE;2021-05-14